A High Epigenetic Risk Score Shapes the Non-Inflamed Tumor Microenvironment in Breast Cancer

Background: Epigenetic dysregulation via aberrant DNA methylation has gradually become recognized as an efficacious signature for predicting tumor prognosis and response to therapeutic targets. However, reliable DNA methylation biomarkers describing tumorigenesis remain to be comprehensively explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dong, Wang, Yingnan, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350480/
https://www.ncbi.nlm.nih.gov/pubmed/34381812
http://dx.doi.org/10.3389/fmolb.2021.675198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350480/
https://www.ncbi.nlm.nih.gov/pubmed/34381812
http://dx.doi.org/10.3389/fmolb.2021.675198

Ejemplares similares